PROAIR HFA

SABA MDI

Albuterol sulfate · Teva Pharmaceuticals

Clinical Reference · Data reviewed June 2026

Discontinued by manufacturer

Teva discontinued branded ProAir HFA effective October 1, 2022. An identical authorized generic (albuterol sulfate inhalation aerosol, Teva) remains available.

Teva authorized generic listing

Active Medication & Mechanism

Albuterol sulfate SABA
90 mcg albuterol per actuation (108 mcg albuterol sulfate)

Short-acting beta2-adrenergic agonist. Produces rapid bronchodilation within 5 minutes by relaxing airway smooth muscle through beta2-receptor stimulation.

FDA-Approved Dosing — Strength × Indication

// approval + regimen in one table

Strength Regimen AsthmaExercise-Induced Bronchospasm

90 mcg

Varies by indication — see columns

FDA Approved

2 inhalations every 4–6 hours as needed → As needed; 1 inhalation may suffice Treatment or prevention of bronchospasm in reversible obstructive airway disease.

FDA Approved

2 inhalations 15–30 minutes before exercise → As needed Prevention of exercise-induced bronchospasm.

All regimens shown apply to adults (≥18 years) unless otherwise noted · verify against current labelling

90 mcg

Asthma FDA Approved

2 inhalations every 4–6 hours as needed → As needed; 1 inhalation may suffice Treatment or prevention of bronchospasm in reversible obstructive airway disease.

Exercise-Induced Bronchospasm FDA Approved

2 inhalations 15–30 minutes before exercise → As needed Prevention of exercise-induced bronchospasm.

All regimens shown apply to adults (≥18 years) unless otherwise noted · verify against current labelling

Rescue inhaler. Indicated for acute bronchospasm and as-needed symptom relief — onset within minutes. Increasing or frequent use signals worsening asthma control; the label advises reassessment of controller therapy.

Related Inhalers

Same active ingredients (Albuterol)

PROAIR DIGIHALER Albuterol · DPI PROAIR RESPICLICK Albuterol · DPI PROVENTIL HFA Albuterol · MDI VENTOLIN HFA Albuterol · MDI

Other SABA inhalers

XOPENEX HFA Levalbuterol · MDI